These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 15538745

  • 1. 5alpha-dihydrotestosterone inhibits 1alpha,25-dihydroxyvitamin D3-induced expression of CYP24 in human prostate cancer cells.
    Lou YR, Nazarova N, Talonpoika R, Tuohimaa P.
    Prostate; 2005 May 15; 63(3):222-30. PubMed ID: 15538745
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.
    Zhao XY, Peehl DM, Navone NM, Feldman D.
    Endocrinology; 2000 Jul 15; 141(7):2548-56. PubMed ID: 10875257
    [Abstract] [Full Text] [Related]

  • 5. Androgen enhances the antiproliferative activity of vitamin D3 by suppressing 24-hydroxylase expression in LNCaP cells.
    Lou YR, Tuohimaa P.
    J Steroid Biochem Mol Biol; 2006 Apr 15; 99(1):44-9. PubMed ID: 16524720
    [Abstract] [Full Text] [Related]

  • 6. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S, Agoulnik IU, Weigel NL.
    Prostate; 2005 Sep 01; 64(4):362-72. PubMed ID: 15754350
    [Abstract] [Full Text] [Related]

  • 7. Regulation of aromatase and 5alpha-reductase by 25-hydroxyvitamin D(3), 1alpha,25-dihydroxyvitamin D(3), dexamethasone and progesterone in prostate cancer cells.
    Lou YR, Murtola T, Tuohimaa P.
    J Steroid Biochem Mol Biol; 2005 Feb 01; 94(1-3):151-7. PubMed ID: 15862960
    [Abstract] [Full Text] [Related]

  • 8. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
    Bareis P, Kállay E, Bischof MG, Bises G, Hofer H, Pötzi C, Manhardt T, Bland R, Cross HS.
    Exp Cell Res; 2002 Jun 10; 276(2):320-7. PubMed ID: 12027461
    [Abstract] [Full Text] [Related]

  • 9. A 24-phenylsulfone analog of vitamin D inhibits 1alpha,25-dihydroxyvitamin D(3) degradation in vitamin D metabolism-competent cells.
    Lechner D, Manhardt T, Bajna E, Posner GH, Cross HS.
    J Pharmacol Exp Ther; 2007 Mar 10; 320(3):1119-26. PubMed ID: 17182978
    [Abstract] [Full Text] [Related]

  • 10. Induction of androgen receptor by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells.
    Zhao XY, Ly LH, Peehl DM, Feldman D.
    Endocrinology; 1999 Mar 10; 140(3):1205-12. PubMed ID: 10067845
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S, Byford V, Arabian A, Sakai Y, Demay MB, St-Arnaud R, Jones G.
    Endocrinology; 2005 Feb 10; 146(2):825-34. PubMed ID: 15498883
    [Abstract] [Full Text] [Related]

  • 14. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ, Peehl DM, Feldman D.
    Endocrinology; 1995 Jan 10; 136(1):20-6. PubMed ID: 7530193
    [Abstract] [Full Text] [Related]

  • 15. Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D.
    Flanagan JN, Young MV, Persons KS, Wang L, Mathieu JS, Whitlatch LW, Holick MF, Chen TC.
    Anticancer Res; 2006 Jan 10; 26(4A):2567-72. PubMed ID: 16886665
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Regulation of matrix metalloproteinase 13 expression by androgen in prostate cancer.
    Pang ST, Flores-Morales A, Skoog L, Chuan YC, Nordstedt G, Pousette A.
    Oncol Rep; 2004 Jun 10; 11(6):1187-92. PubMed ID: 15138554
    [Abstract] [Full Text] [Related]

  • 18. Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines.
    Miller GJ, Stapleton GE, Hedlund TE, Moffat KA.
    Clin Cancer Res; 1995 Sep 10; 1(9):997-1003. PubMed ID: 9816072
    [Abstract] [Full Text] [Related]

  • 19. Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity.
    Wang LG, Liu XM, Kreis W, Budman DR.
    Biochem Biophys Res Commun; 1999 May 27; 259(1):21-8. PubMed ID: 10334909
    [Abstract] [Full Text] [Related]

  • 20. Androgen receptor-mediated repression of novel target genes.
    Prescott J, Jariwala U, Jia L, Cogan JP, Barski A, Pregizer S, Shen HC, Arasheben A, Neilson JJ, Frenkel B, Coetzee GA.
    Prostate; 2007 Sep 15; 67(13):1371-83. PubMed ID: 17624924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.